Jie Shen

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 05, 2026
Personalized therapeutic platform: organoid models for hepatic malignancies.

|Feb 26, 2026
From spectroscopic analysis to clinical imaging: emerging applications and persistent challenges of raman spectroscopy in CTCs-based liquid biopsies.

Juan Zhang, Jie Shen

|Nov 27, 2025
Probiotics lead to a new frontier in tumor fighting: tumor vaccines based on probiotics.

Tingting Ma, Liang Qi, Ziyan Zhou

|Oct 08, 2025
Novel tetrameric bispecific KK-LC-1×CD16A-armed memory-like NK cells enhance antitumor efficacy in gastric cancer.

Mengzhu Li, Tianran Chen, Siwen Wu

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

|Jan 21, 2025
Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression.

Mingzhen Zhou, Ziyan Zhou, Lina Hu

Pageof 2

Frequent Collaborators

2 joint publications

Baorui Liu

2 joint publications

Ziyan Zhou

1 joint publications

Jingyi Guo

1 joint publications

Zhan Shi